These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15293509)

  • 1. [HIV-1 serotyping of V3-mimicking peptides circulating in the Republic of Tajikistan among intravenous drug users].
    Burunova VV; Shchelkanov MIu; Tishkova FKh; Starikov NS; Pazilin AS; Belobrova EA; Petrenko MS; Iudin AN; Samuilov VD; Garaev MM; L'vov DK
    Vopr Virusol; 2004; 49(4):30-9. PubMed ID: 15293509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serotypical stratification of HIV-1 in populations of intravenous drug users in the south/southwestern Ukraine].
    Shchelkanov MIu; Iaroslavtseva NG; Nabatov AA; Masharskiĭ AE; Iudin AN; Mirskov IuA; Chentsova NP; Kobyshcha IuV; Kozlov AP; Karamov EV
    Vopr Virusol; 1998; 43(4):176-82. PubMed ID: 9791884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly specific V3 peptide enzyme immunoassay for serotyping HIV-1 specimens from Thailand.
    Pau CP; Lee-Thomas S; Auwanit W; George JR; Ou CY; Parekh BS; Granade TC; Holloman DL; Phillips S; Schochetman G
    AIDS; 1993 Mar; 7(3):337-40. PubMed ID: 8471195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serological properties of HIV-1 isolates from the focus of an epidemic in the Gomel region of the Belarus Republic (1996)].
    Shchelkanov MIu; Iaroslavtseva NG; Iudin AN; Mirskov IuA; Eremin VF; Titov LP; Rytik PG; Karamov EV
    Vopr Virusol; 1998; 43(5):220-9. PubMed ID: 9864827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV type 1 V3 serotyping of Tanzanian samples: probable reasons for mismatching with genetic subtyping.
    Hoelscher M; Hanker S; Barin F; Cheingsong-Popov R; Dietrich U; Jordan-Harder B; Olaleye D; Nägele E; Markuzzi A; Mwakagile D; Minja F; Weber J; Gürtler L; Von Sonnenburg F
    AIDS Res Hum Retroviruses; 1998 Jan; 14(2):139-49. PubMed ID: 9462924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroreactivity to HIV-1 V3 subtypes A to H peptides of Argentinian HIV-positive sera.
    Devito C; Levi M; Hinkula J; Fernandez Medina RD; Libonatti O; Wigzell H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Feb; 17(2):156-9. PubMed ID: 9473017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotyping of HIV type 1 infections: definition, relationship to viral genetic subtypes, and assay evaluation. UNAIDS Network for HIV-1 Isolation and Characterization.
    Cheingsong-Popov R; Osmanov S; Pau CP; Schochetman G; Barin F; Holmes H; Francis G; Ruppach H; Dietrich U; Lister S; Weber J
    AIDS Res Hum Retroviruses; 1998 Mar; 14(4):311-8. PubMed ID: 9519892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania.
    Lukashov VV; Cornelissen MT; Goudsmit J; Papuashvilli MN; Rytik PG; Khaitov RM; Karamov EV; de Wolf F
    AIDS; 1995 May; 9(5):435-9. PubMed ID: 7639968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodies.
    Polonis VR; De Souza MS; Chanbancherd P; Chantakulkij S; Jugsudee A; Loomis-Price LD; Vancott TC; Garner R; Markowitz LE; Brown AE; Birx DL
    AIDS Res Hum Retroviruses; 2001 Jan; 17(1):69-79. PubMed ID: 11177385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroreactivity of analogous antigenic epitopes in glycoprotein 120 expressed in HIV-1 subtypes A, B, C, and D.
    Pestano GA; Hosford KS; Spira AI; Riley J; Xie JM; Sewankambo N; Brown L; Ho DD; Boto WM
    AIDS Res Hum Retroviruses; 1995 May; 11(5):589-96. PubMed ID: 7576915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. WHO Network for HIV Isolation and Characterization.
    Cheingsong-Popov R; Lister S; Callow D; Kaleebu P; Beddows S; Weber J
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1379-86. PubMed ID: 7888191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the specificity of the human antibody response to the V3 neutralization domain of HIV-1.
    Zwart G; Wolfs TF; Valk M; Van der Hoek L; Kuiken CL; Goudsmit J
    AIDS Res Hum Retroviruses; 1992 Nov; 8(11):1897-908. PubMed ID: 1489578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of linear antigenic epitopes on GP120 encoded in sibling clones of novel New York HIV-1 subtype B isolates.
    Riley JP; Pestano GA; Harewood K; Alfred LJ; Guyden J; Boto WM
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S83-91. PubMed ID: 8574151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. V3 serological subtyping of human immunodeficiency virus type 2 infection is not relevant.
    Plantier JC; Damond F; Souquières S; Brun-Vézinet F; Simon F; Barin F
    J Clin Microbiol; 2001 Oct; 39(10):3803-7. PubMed ID: 11574625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between HIV type 1 disease progression and V3 serotype in a rural Ugandan cohort.
    Senkaali D; Muwonge R; Morgan D; Yirrell D; Whitworth J; Kaleebu P
    AIDS Res Hum Retroviruses; 2004 Sep; 20(9):932-7. PubMed ID: 15585080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological approaches to subtyping of HIV-1 in injecting drug users in Russia: evidence of subtype homogeneity at the main sites of the epidemic.
    Bobkova MR; Kazennova EV; Selimova LM; Buravtsova EV; Lister S; Prilipov AG; Weber JN; Pokrovsky VV; Bobkov AF
    Int J STD AIDS; 2001 Jan; 12(1):34-40. PubMed ID: 11177480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies on neutralisation of primary HIV-1 isolates by human sera and rabbit anti-V3 peptide sera.
    Lawoko AL; Johansson B; Hjalmarsson S; Christensson B; Ljungberg B; Al-Khalili L; Sjölund M; Pipkorn R; Fenyö EM; Blomberg J
    J Med Virol; 1999 Oct; 59(2):169-79. PubMed ID: 10459152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of no change in V3 loop antibody recognition pattern in HIV type 1-infected Ethiopians between 1988 and 1993.
    Sherefa K; Sällberg M; Sönnerborg A
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1551-6. PubMed ID: 7534097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic, antigenic and serologic characterization of human immunodeficiency virus type 1 from Indonesia.
    Porter KR; Mascola JR; Hupudio H; Ewing D; VanCott TC; Anthony RL; Corwin AL; Widodo S; Ertono S; McCutchan FE; Burke DS; Hayes CG; Wignall FS; Graham RR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jan; 14(1):1-6. PubMed ID: 8989203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent and early HIV-1MN neutralizing capacity in sera from Dutch HIV-1 seroconverters is related to antibody reactivity to peptides from the gp120 V3 domain.
    Zwart G; Back NK; Ramautarsing C; Valk M; van der Hoek L; Goudsmit J
    AIDS Res Hum Retroviruses; 1994 Mar; 10(3):245-51. PubMed ID: 8018385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.